Thoracic Outlet Syndrome Market Research Report Information: By Type (Neurogenic, Venous, Arterial Thoracic Outlet Syndrome) Diagnosis (Ct Scan, Mri Scan, Blood Tests, Arteriogram), Treatment (Surgery, Medication), End-User- Forecast Till 2027
ID: MRFR/MED/4100-HCR | February 2021 | Region: Global | 85 pages
Thoracic Outlet Syndrome Market Scenario
Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome. Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.
Rising cases of trauma and car accidents are boosting the growth of the thoracic outlet syndrome market. Chest injury is one of the causes of thoracic outlet syndrome, and this comes about as a result of traffic accidents in which the collarbone is broken, and the upper ribs are injured. As per the World Health Organization (WHO) report, nearly 20-50 million people incur non-fatal injuries as a result of road traffic accidents.
Other factors such as increasing cases of anatomical defects, high unmet needs of current treatment, and surge in the research and development expenditure, improvement in reimbursement policies are also expected to drive the growth of the market. According to a study published in the Current Issues in Pharmacy and Medical Sciences - De Gruyter journal in 2015, it is found that bone abnormality may be a potential cause of thoracic outlet syndrome. The most common bone abnormalities include irregularities of the clavicle (20%), the cervical rib (70% of cases), and in the different structures of the first rib (10%).
Despite these drivers, there are some issues associated with thoracic outlet syndrome market. Lack of infrastructure in the middle and low-income countries and side effects associated with the drugs may hamper the growth of the market.
It is estimated that thoracic outlet syndrome market is expected to grow at a CAGR 7.0% during the forecast period of 2017-2023.
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Thoracic Outlet Syndrome MarketSegmentation
The thoracic outlet syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market Thoracic Outlet Syndrome Marketis segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
On the basis of diagnosis, the market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), and magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.
On the basis of treatment, the market is segmented into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxant, thrombolytic medications, anticoagulant medications, and others.
On the basis of end-user, the market is segmented into hospital & Clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.
Thoracic Outlet Syndrome Market Regional Analysis
The Americas dominate the thoracic outlet syndrome market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.
Europe holds the second position in the thoracic outlet syndrome market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.
Asia Pacific is the fastest growing in thoracic outlet syndrome market, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014–15.
The Middle East & Africa has the lowest market for thoracic outlet syndrome due to lack of technical knowledge and poor medical facilities.
Thoracic Outlet Syndrome Market Key Players
Some of key the players in the market are Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others.
Intended Audience
- Hospitals
- Diagnostic Clinics
- Research and Development (R&D) Companies
- Government Research Institute
- Academic Institutes and Universities
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 2017-2023: 7.0% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Diagnosis, Treatment, and End-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Thoracic outlet syndrome market CAGR would be 7% during the forecast period.
North America would dominate the thoracic outlet syndrome market.
The treatment types discussed in the thoracic outlet syndrome market report are medications, physical therapy, surgery, and others.
Europe is the second-largest thoracic outlet syndrome market region.
The players discussed in the thoracic outlet syndrome market are Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Abbott Laboratories, Upsher Smith Laboratories, Inc., Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Daiichi Sankyo, Orient Pharma Co., Ltd., Par Sterile Products, LLC., Mallinckrodt plc., SteriMax Inc., Sanofi, Vertical Pharmaceuticals LLC, and others.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Thoracic Outlet Syndrome Market, By Type
6.1 Introduction
6.2 Neurogenic Thoracic Outlet Syndrome
6.2.1 Market Estimates & Forecast, 2020 – 2027
6.3 Venous Thoracic Outlet Syndrome
6.3.1 Market Estimates & Forecast, 2020 – 2027
6.4 Arterial Thoracic Outlet Syndrome
6.4.1 Market Estimates & Forecast, 2020 – 2027
Chapter 7. Global Thoracic Outlet Syndrome Market, By Diagnosis
7.1 Introduction
7.2 Nerve Conduction Studies
7.2.1 Market Estimates & Forecast, 2020 – 2027
7.3 Vascular Studies
7.3.1 Market Estimates & Forecast, 2020 – 2027
7.4 Chest X-Ray
7.4.1 Market Estimates & Forecast, 2020 – 2027
7.5 Computed Tomography (CT) Scan
7.5.1 Market Estimates & Forecast, 2020 – 2027
7.6 Magnetic Resonance Imaging (MRI)
7.6.1 Market Estimates & Forecast, 2020 – 2027
7.7 Magnetic Resonance Imaging With Angiography (MRA)
7.7.1 Market Estimates & Forecast, 2020 – 2027
7.8 Arteriogram/Venogram
7.8.1 Market Estimates & Forecast, 2020 – 2027
7.9 Blood Tests
7.9.1 Market Estimates & Forecast, 2020 – 2027 Chapter 8. Global Thoracic Outlet Syndrome Market, By Treatment
8.1 Introduction
8.2 Surgery
8.2.1 Market Estimates & Forecast, 2018 – 2023
8.3 Medications
8.3.1 Market Estimates & Forecast, 2018 – 2023
8.4 Physical Therapy
8.4.1 Market Estimates & Forecast, 2018 – 2023
8.5 Others
8.5.1 Market Estimates & Forecast, 2018 – 2023 Chapter 9. Global Thoracic Outlet Syndrome Market, By End User
9.1 Introduction
9.2 Hospital & Clinics
9.2.1 Market Estimates & Forecast, 2020 – 2027
9.3 Diagnostic Centers
9.3.2 Market Estimates & Forecast, 2020 – 2027
9.4 Academic And Research Institutes
9.4.1 Market Estimates & Forecast, 2020 – 2027
9.5 Others
9.5.2 Market Estimates & Forecast, 2020 – 2027
Chapter 10. Global Thoracic Outlet Syndrome Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest Of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic Of Korea
10.4.6 Rest Of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest Of The Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Types Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Bayer AG
11.2.1 Company Overview
11.2.2 Types Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Boehringer Ingelheim
11.3.1 Company Overview
11.3.2 Types Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Johnson & Johnson Services, Inc.
11.4.1 Company Overview
11.4.2 Types/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Sanofi
11.5.1 Company Overview
11.5.2 Types Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.6 Vertical Pharmaceuticals LLC
11.6.1 Company Overview
11.6.2 Types Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 DAIICHI SANKYO
11.7.1 Overview
11.7.2 Types Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Prediction Of Thoracic Outlet Syndrome Industry
Chapter 13 Appendix LIST OF TABLES
Table 1 Thoracic Outlet Syndrome Industry Synopsis, 2020 – 2027
Table 2 Thoracic Outlet Syndrome Market Estimates And Forecast, 2020 – 2027, (USD Million)
Table 3 Thoracic Outlet Syndrome Market By Region, 2020 – 2027, (USD Million)
Table 4 Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 5 Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 6 Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 7 Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 8 North America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 9 North America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 10 North America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 11 North America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 12 US Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 13 US Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 14 US Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 15 US Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 16 Canada Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 17 Canada Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 18 Canada Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 19 Canada Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 20 South America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 21 South America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 22 South America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 23 South America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 24 Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 25 Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 26 Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 27 Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 28 Western Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 29 Western Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 30 Western Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 31 Western Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 32 Eastern Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 33 Eastern Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 34 Eastern Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 35 Eastern Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 36 Asia Pacific Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 37 Asia Pacific Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 38 Asia Pacific Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 39 Asia Pacific Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 40 Middle East & Africa Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 41 Middle East & Africa Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 42 Middle East & Africa Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 43 Middle East & Africa Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES Figure 1 Research Process
Figure 2 Segmentation For Thoracic Outlet Syndrome Market
Figure 3 Segmentation Market Dynamics For Thoracic Outlet Syndrome Market
Figure 4 Global Thoracic Outlet Syndrome Market Share, By Type 2020
Figure 5 Global Thoracic Outlet Syndrome Market Share, By Diagnosis 2020
Figure 6 Global Thoracic Outlet Syndrome Market Share, By Treatment 2020
Figure 7 Global Thoracic Outlet Syndrome Market Share, By End Users, 2020
Figure 8 Global Thoracic Outlet Syndrome Market Share, By Region, 2020
Figure 9 North America Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 10 Europe Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 11 Asia Pacific Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 12 Middle East & Africa Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 13 Global Thoracic Outlet Syndrome Market: Company Share Analysis, 2020 (%)
Figure 14 Abbott Laboratories: Key Financials
Figure 15 Abbott Laboratories Segmental Revenue
Figure 16 Abbott Laboratories: Geographical Revenue
Figure 17 Bayer AG: Key Financials
Figure 18 Bayer AG: Segmental Revenue
Figure 19 Bayer AG: Geographical Revenue
Figure 20 Boehringer Ingelheim: Key Financials
Figure 21 Boehringer Ingelheim: Segmental Revenue
Figure 22 Boehringer Ingelheim: Geographical Revenue
Figure 23 Johnson & Johnson Services, Inc.: Key Financials
Figure 24 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 25 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 26 Sanofi: Key Financials
Figure 27 Sanofi: Segmental Revenue
Figure 28 Sanofi Geographical Revenue
Figure 29 Vertical Pharmaceuticals LLC: Key Financials
Figure 30 Vertical Pharmaceuticals LLC: Segmental Revenue
Figure 31 Vertical Pharmaceuticals LLC: Geographical Revenue
Figure 32 DAIICHI SANKYO: Key Financials
Figure 33 DAIICHI SANKYO: Segmental Revenue
Figure 34 DAIICHI SANKYO: Geographical Revenue
Bottom of Form